Skip to main content

Table 1 Association of BCCIP expression with triple negativity, p53, and BRCA1 status in breast cancer tissues

From: Roles of BCCIP deficiency in mammary tumorigenesis

  BCCIP (−) BCCIP (+) Total cases p value
All cases 156 (33%) 317 (67%) 473  
Triple negative 66 (49%) 70 (51%) 136 3.86 × 10–7
Nontriple negative 80 (25%) 247 (75%) 327
p53 wild type 133 (35%) 252 (65%) 385 0.0018
p53 mutant 12 (16%) 62 (84%) 74
BRCA1 mutant (all triple negative) 1 (8%) 11 (92%) 12 0.0073 (compared with triple-negative tumors)